Print“It is vitally important that we support the development of companies with promising technologies or business models that are aligned with our strategy and have the potential to shape the future of healthcare.”
The industrial giant GE plans to boost its already sizeable presence in the healthcare arena with the establishment of the “GE Healthymagination Fund,” a $250 million equity fund that will make investments in healthcare technology companies. The fund will invest in companies globally that have innovative diagnostic, information technology, and life sciences technologies that fit with the strategic objectives of the company’s Healthymagination initiative, a $6 billion effort to deliver better healthcare to more people at lower cost.
In addition, the fund will support healthcare companies developing innovative and unique business models and services, the company said.
The company said the new fund will target three broad areas for investment:
- Broad-based Diagnostics, including imaging, home health, patient monitoring, molecular diagnostics, pathology, novel imaging agents and other technologies for disease diagnosis.
- Healthcare Information Technology, including electronic medical records, clinical information systems, healthcare information exchanges and value-added data services.
- Life Sciences, including tools for research and development in biopharmaceuticals and stem cells, and technologies for manufacturing of biopharmaceuticals and vaccines.
“As GE works on solutions to healthcare’s biggest challenges, it is vitally important that we support the development of companies with promising technologies or business models that are aligned with our strategy and have the potential to shape the future of healthcare,” GE Chairman and CEO Jeffrey Immelt says. “This includes smarter processes and technologies that measurably increase access to healthcare, reduce the cost of delivery and improve quality.”
.jpg)
.gif)
.gif)
.gif)
